SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Bahmanyar Shahram)
 

Sökning: WFRF:(Bahmanyar Shahram) > Non-steroidal anti-...

  • Bergendal, Annica (författare)

Non-steroidal anti-inflammatory drugs and venous thromboembolism in women

  • Artikel/kapitelEngelska2013

Förlag, utgivningsår, omfång ...

  • 2013-03-19
  • Wiley,2013
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-203550
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-203550URI
  • https://doi.org/10.1002/pds.3436DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:127003495URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background Non-steroidal anti-inflammatory drugs (NSAIDs) might increase the risk of venous thromboembolism (VTE), and risks might differ by type of NSAID. Compared with men, women have a higher incidence of VTE at younger age, and they more often use NSAIDs. Objectives To assess risks of VTE in young and middle-aged women in association with use of NSAIDs. Patients/Methods In a nationwide case-control study (Thrombo Embolism Hormone Study) performed in Sweden 2003-2009, we included as cases 1433 women, 18 to 64years of age with a first time VTE. Controls were 1402 randomly selected women, frequency matched by age. Information was obtained by telephone interviews and DNA analyses of blood samples. We calculated adjusted odds ratios (ORs) with 95% confidence intervals (CIs) adjusting for degree of immobilization, chronic disease, smoking, body mass index, use of hormonal contraception, hormone therapy or other NSAIDs. Results Use of NSAIDs was not associated with increased risks of VTE (OR=0.98, 95% CI 0.80-1.19). The OR was 0.88 for propionic acid derivatives (95% CI 0.72-1.10), 1.18 for acetic acid derivatives (95% CI 0.82-1.70) and 1.76 for coxibs (95% CI 0.73-4.27). For users of acetic acid derivatives and coxibs, the ORs increased by cumulative dose. Carriership of the prothrombin gene mutation or factor V Leiden had only minor effects on the results. Conclusions We found no increased risks of VTE in association with use of NSAIDs. Users of high cumulative doses of acetic acid derivatives and coxibs had the highest risks, suggesting a relationship with cyclooxygenase selectivity and dose.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Adami, Johanna (författare)
  • Bahmanyar, ShahramKarolinska Institutet (författare)
  • Hedenmalm, KarinUppsala universitet,Klinisk farmakologi (författare)
  • Larfars, GerdKarolinska Institutet (författare)
  • Persson, Ingemar (författare)
  • Sundstrom, AndersKarolinska Institutet (författare)
  • Kieler, HelleKarolinska Institutet (författare)
  • Karolinska InstitutetKlinisk farmakologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Pharmacoepidemiology and Drug Safety: Wiley22:6, s. 658-6661053-85691099-1557

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy